‘Meaningful improvement in vision’ seen in ELARA study

ORLANDO — In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, said aflibercept 8 mg showed vision improvement and a reduction in retinal thickness.
The ELARA study evaluated frequent dosing of Eylea HD (aflibercept 8 mg, Regeneron) in eyes with previously treated diabetic macular edema or wet age-related macular degeneration. Patients received aflibercept 8 mg for seven monthly injections and then switched to a treat-and-extend regimen after week 24.
Patients with previously treated neovascular AMD experienced a gain of 2.3 letters and a mean reduction